| GlaxoSmithKline AG - Fluarix Tetra 15 µg / 0.5 ml, Injektionssuspension | | 62961 | | 07 | | Fluarix Tetra 15 µg / 0.5 ml | | Injektionssuspension | | J07BB02 | | Influenza, Inactivated, Split Virus Or Surface Antigen | | 23.07.2020 | | |
| | Composition | | haemagglutininum influenzae A (H1N1) (Virus Stamm A/Guangdong-Maonan/SWL1536/2019 (H1N1)-like: reassortant virus CNIC-1909 derived from A/Guangdong-Maonan/SWL1536/2019) 15 µg, haemagglutininum influenzae A (H3N2) (Virus Stamm A/Hong Kong/2671/2019 (H3N2)-like: reassortant virus NIB-121 derived from A/Hong Kong/2671/2019) 15 µg, haemagglutininum influenzae B (Virus Stamm B/Washington/02/2019-like: reassortant virus B/Washington/02/2019 (Victoria lineage)) 15 µg, haemagglutininum influenzae B (Virus Stamm B/Phuket/3073/2013 (Yamagata lineage)) 15 µg, polysorbatum 80, octoxinolum-10, natrii chloridum, magnesii chloridum hexahydricum, dinatrii phosphas dodecahydricus, kalii dihydrogenophosphas, kalii chloridum, alpha-tocopheroli hydrogenosuccinas, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml, residui: ovalbuminum, formaldehydum, natrii desoxycholas, gentamicini sulfas, hydrocortisonum. | | Packungsbestandteile | | Injection suspension | | | | | | Active Agent | Dose |
|---|
| | 15 µg | | | 15 µg | | | 15 µg |
| | | | Inactive agents | Dose |
|---|
| | | | Disodium Phosphate Dodecahydrate | | | | 15 µg | | Potassium Chloride | | | Potassium Dihydrogenophosphate | | | Magnesium Chloride Hexahydrate | | | Sodium Chloride | | | | | | Polysorbatum 80 | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
|
